Intellectus Partners, LLC Proto Kinetix, Inc. Transaction History

Intellectus Partners, LLC

  • $383 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 13, 2018
SELL
$0.05 - $0.07 $2,307 - $3,230
-46,150 Closed
0 $0
Q2 2017

Aug 15, 2017
BUY
N/A
46,150
46,150 $3,000

Others Institutions Holding PKTX

# of Institutions
2
Shares Held
70.6K
Call Options Held
0
Put Options Held
0
View Full List

About ProtoKinetix, Inc.

PKTX Quotes by TradingView
  • Ticker PKTX
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 314,329,984
  • Market Cap $3.14M
  • Description
  • ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collabo...
More about PKTX
Track This Portfolio

Track Intellectus Partners, LLC Portfolio

Follow Intellectus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email